Claims for Patent: 10,124,064

Summary for Patent: 10,124,064

Title:	Antimicrobial compositions of aminoglycosidic antibiotics and zinc ion chelators specifically formulated for enhanced inhibition of bacterial colonization and antibacterial efficacy
Abstract:	Pharmaceutical compositions comprising an aminoglycosidic antibiotic and at least one zinc-chelating agent in a specified concentration, and methods of inhibiting bacterial colonization, biofilm formation and if treating bacterial infections utilizing the compositions are provided. Topical formulations suitable for wound care, and surface-applicable formulations suitable for medical, industrial and household disinfecting needs are also described.
Inventor(s):	Herr; Andrew B. (Cincinnati, OH), Young; Gary (Hopkinton, MA)
Assignee:	University of Cincinnati (Cincinnati, OH)
Application Number:	15/783,509
Patent Claims:	1. A method of formulating a pharmaceutical composition comprising about 0.1% gentamicin by weight and about 5 to 15 mg/ml diethylenetriamine pentaacetic acid (DTPA) as a topical formulation, the method comprising: providing a base vessel of suitable oil-in-water emulsion base maintained at about 60.degree. C.; preparing an aliquot solution in a first vessel by adding an amount of DTPA to an amount of sterile water and mixing until uniform; transferring a specified volume of the aliquot to a second vessel and adding gentamicin sulfate while mixing until the gentamicin sulfate is substantially fully dissolved; heating the base in the base vessel to about 90.degree. C. while stirring; filtering and transferring the entire contents of the second vessel to the base vessel; mixing until uniform; cooling to about 55.degree. C.; transferring to a sterilization vessel and sterilizing. 2. The method according to claim 1, wherein the pharmaceutical composition is in the form of an ointment, a cream, or a lotion. 3. The method according to claim 1, wherein the DTPA is Na.sub.5DTPA or Na.sub.3CaDTPA. 4. The method according to claim 1, wherein the DTPA is Na.sub.3CaDTPA. 5. The method according to claim 1, wherein the oil-in-water emulsion base further comprises one or more of a thickening agent, a gelling agent, an emulsifying agent, a stabilizing agent, a dispersing agent, a suspending agent, or a coloring agent. 6. The method according to claim 1, wherein the oil-in-water emulsion base comprises glyceryl stearate/PEG-100, lanolin alcohol powder, cetyl alcohol powder, mineral oil, sorbitol 70% solution, and distilled water. 7. The method according to claim 6, wherein providing an oil-in-water emulsion base comprises the steps of: (a) combining the distilled water and the sorbitol 70% solution in a first receptacle and mixing until uniform; (b) filtering the solution of step (a); (c) combining the glycerol stearate/PEG-100, lanolin alcohol powder, cetyl alcohol powder, and mineral oil in a second receptacle and heating to about 70.degree. C.; (d) sterilizing the solution of step (c) by dry heat; (e) heating the solution of step (d) to about 90.degree. C. under sterile conditions; (f) heating the solution of step (b) to about 90.degree. C. under sterile conditions; (g) adding the solution of step (f) to the solution of step (e) and mixing to combine; and (h) cooling the solution of step (g) to about 60.degree. C. to provide an oil-in-water emulsion base. 8. A method of treating a wound in a subject, the method comprising topically applying to the wound a pharmaceutical composition comprising about 0.1% gentamicin by weight, about 5 to 15 mg/ml diethylenetriamine pentaacetic acid (DTPA), and an oil-in-water emulsion base.

Details for Patent 10,124,064

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2033-04-16